[Antimicrobial effectiveness of azlocillin in cholesteatoma in parenteral administration].
Joachim C. Mertens(GastroZentrum Hirslanden Zürich), U. Ullmann(Christian-Albrechts-Universität zu Kiel), J. Wustrow
PubMed
October 1, 1988
Cited by 1
Related Papers
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score
|Journal of Hepatology|2021|309